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ABSTRACT
IEDB-3D is the 3D structural component of the
Immune Epitope Database (IEDB) available via the
‘Browse by 3D Structure’ page at http://www.iedb
.org. IEDB-3D catalogs B- and T-cell epitopes and
Major Histocompatibility Complex (MHC) ligands for
which 3D structures of complexes with antibodies,
T-cell receptors or MHC molecules are available in
the Protein Data Bank (PDB). Journal articles that
are primary citations of PDB structures and that
define immune epitopes are curated within IEDB
as any other reference along with accompanying
functional assays and immunologically relevant
information. For each curated structure, IEDB-3D
provides calculated data on intermolecular
contacts and interface areas and includes an
application, EpitopeViewer, to visualize the
structures. IEDB-3D is fully embedded within IEDB,
thus allowing structural data, both curated and
calculated, and all accompanying information to be
queried using multiple search interfaces. These
include queries for epitopes recognized in different
pathogens, eliciting different functional immune
responses, and recognized by different components
of the immune system. The query results can be
downloaded in Microsoft Excel format, or the
entire database, together with structural data both
curated and calculated, can be downloaded in either
XML or MySQL formats.
INTRODUCTION
The Immune Epitope Database (IEDB) (1) catalogs
experimentally identiﬁed B- and T-cell epitopes and
MHC ligands through manual curation of the scientiﬁc
literature. By the end of 2011, all published epitopes
from infectious agents [except HIV, which are maintained
in (2)], allergens and autoimmune diseases should be
included in the IEDB. In addition, all epitopes
characterized by 3D structures of immune receptors
complexed with antigens found in the Protein Data
Bank (PDB) (3) will be included, independent of the
disease association of the antigen. This expansion in
scope is made as to understand the general structural
principles of epitope recognition a large dataset is
desirable, but detailed 3D structural information on
epitope complexes is rare.
The 3D structural component of IEDB, called here
IEDB-3D, is embedded seamlessly within the general
IEDB, thus ensuring that each reference describing
3D structure is curated within IEDB as any other
journal article describing immune epitopes. The focus
on curation of immunological and epitope relevant
information is the major difference between
IEDB and IMGT/3Dstructure-DB (4). Similar to
IMGT/3Dstructure-DB (4) and other related databases,
such as MPID-T (5), Epitome (6), BEID (7) and CED
(8), IEDB provides calculated data on intermolecular
contacts and interface areas and includes an application
to visualize the structure, EpitopeViewer (9), which is a
high-quality graphic and rendering tool. Among the
aforementioned databases, only CED and IEDB curate
epitope residues from the literature. In IEDB, antibody,
MHC and T-cell receptor (TCR) residues interacting with
the epitope are also curated if they are provided in the
reference. Thus, within IEDB, curated and derived data
on epitope and antigen–receptor interactions can be seen
and compared side-by-side on the IEDB web page and
also through launching EpitopeViewer.
IEDB-3D OVERVIEW
IEDB-3D is fully integrated within IEDB, with its data
structure, ontology and query interface indistinguishable
from those of the IEDB database. IEDB-3D is the 3D
structural component of the Immune Epitope Database
(IEDB) available via the ‘Browse by 3D Structure’ page
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types of curated data include experiments describing
recognition of epitopes or antigens (peptidic or non-
peptidic) by TCRs (T-cell assays describing 3D structures
of antigens/epitopes in complexes with MHC and TCR),
immunoglobulins or antibodies (B-cell assays describing
structures of antibody–antigen complexes), and MHC
molecules (MHC binding assays describing structures of
antigens/epitopes in complex with MHC) (Figure 2).
Curation of 3D complex data is handled like the
remaining data in the IEDB, except that all epitopes are
considered in scope, including those from HIV or cancer.
IEDB does not handle HIV data, if the paper provides
only information on immunological assay involving HIV
antigen explicitly, since these data are curated in HIV
database (2). However, if 3D structural data are available
for HIV epitopes, they are curated, but with a lower
priority compared to other 3D structural data. In
IEDB-3D, in addition to the immunological context
curated for all epitopes in IEDB, information on 3D
structure is provided in the section ‘3D Structure of
Complex’ (Figure 3).
An overview of IEDB-3D content is given in Table 1.
Current statistics on the number of distinct epitope
structures curated by assay type and source organism
can be accessed from the ‘Browse by 3D Structure’ page
(Figure 1, red box).
CURATION OF 3D STRUCTURAL DATA
The process of curating epitopes from 3D structures is
shown in Figure 2. To be curated, the paper describing
the structure (primary citation in PDB) should be
published; likewise the paper describing the structure
cannot be curated if the structure has not been deposited
in PDB, unless this article describes the epitope in the
Figure 1. The screen shot of IEDB web page.
Figure 2. Objects, processes and roles as represented in IEDB-3D.
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PDB structure and journal article, which is a primary
reference of the structure are considered as sources of
information for curation.
Similar to other assays, for 3D structures, data on
epitope molecular structure, epitope source, immunization
that led to recognition of the epitope, assay, antigen,
antibody, TCR or MHC are curated according to IEDB
general procedure (1). An example of a B-cell response
is given in Figure 3. The difference of IEDB-3D
data compared to regular IEDB curations is the
information captured under the ‘3D Structure of
Complex’ heading.
In general, studies often do not provide the exact
epitope structure recognized by an antibody/B-cell
receptor, especially in the case of discontinuous B-cell
epitopes. Therefore, discontinuous epitopes are often
curated as partial epitopes, with only a few key residues
captured. In cases where the epitope is curated from
the structure this can be avoided; if the authors of the
paper stated that only residues for part of the
epitope were provided, we calculate the epitope
residues from the PDB structure as the antigen residues
separated from the antibody by 4A ˚ atomic distance
(T-cell epitopes are curated as whole peptides or non-
peptidic structures). The mapping between the numbers
of the epitope residues provided in the paper and the
external database is done manually, using the mapping
between the PDB and UniProt numberings provided on
the PDB website. For example, the epitope shown in
Figure 3 had different residue numbers in the paper
(‘Reference Region’ ﬁeld at the top in Figure 3)
compared to the numbering that matches the source
Figure 3. Example of the B-cell response page. Detailed information is
provided for the epitope (blue box) and B-cell response, including data
on the immunization (purple box), assay (teal box), antibody (yellow
box), antigen used in the X-ray crystallography experiment (green box)
and the 3D structure of antigen-antibody complex (red box). The
antigen-antibody interactions were curated from (12) and calculated
from the coordinates provided in the PDB ﬁle [PDB: 1YNT]. The
results of clicking on the links ‘View 3D Structure’ and ‘View
Contacts XML ﬁle’ (red arrows) are shown in Figure 4.
Table 1. IEDB-3D content
Epitope type Total number
of references
a
Curated
references
b
IEDB category
Infectious diseases Peptidic 131 131
Non-peptidic 11 4
Allergy Peptidic 8 8
Non-peptidic 5 3
Autoimmunity Peptidic 39 30
Non-peptidic 11 11
Cancer Peptidic 40 16
Non-peptidic 8 5
Transplant Peptidic 22 18
Non-peptidic 2 1
Other Peptidic 241 130
Non-peptidic 82 2
HIV 55 4
Total 655 365
Structural category
B-cell epitopes Peptidic 311 168
Non-peptidic 108 20
T-cell epitopes Peptidic 217 177
Non-peptidic 19 0
Total 655 365
aPDB and PubMed search as of January 7, 2010.
bCuration status as of January 9, 2010.
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(‘Discontinuous Residues’ ﬁeld).
Information on the 3D structure is provided in the
section ‘3D Structure of Complex’. There are three
types of tables with different ﬁelds for B-cell, T-cell and
MHC-binding, respectively. The ﬁelds curated for B-cell
responses, or structures of antibody–antigen complexes,
are shown in Figure 3. The following structural
information is curated: PDB ID, antibody and antigen
chain IDs, epitope and antibody residues in PDB
numbering, as well as CDR loops for the antibody
residues and contact surface areas for the antibody and
antigen if they are provided in the paper.
Interacting residues and contact areas are also
calculated. The former are deﬁned based on 4-A ˚ atomic
distance, according to the deﬁnition from (10), the latter
are calculated using the NACCESS program (11).
Pairwise atomic contacts are provided in the XML ﬁles
available via hyperlinks (Figure 3) ‘View Curated
Contacts XML ﬁle’ and ‘View Calculated Contacts
XML ﬁle’. The ﬁrst link is provided only if the contacts
were speciﬁed in the journal article and curated, the latter
link allows the user to view and download the ﬁle
providing calculated antibody–antigen (antigen-MHC, or
antigen-TCR and MHC-TCR) inter-molecular contacts
(Figure 4C). The following types of contacts are
calculated: hydrogen bonds, salt bridges, van der Waals,
hydrophobic and 4-A ˚ interactions (interactions
are deﬁned in the EpitopeViewer tutorial at http://spdc
.sdsc.edu/iedb/epitopeViewer/EpitopeViewerTutorial_v2
.0.htm; this link is also available inside the EpitopeViewer
application). The calculation is done during curation,
using a php program that takes as an input curated data
and PDB ﬁle and outputs two XML ﬁles with the
interacting residues, contact areas and pairwise contacts.
These ﬁles are also used as input for EpitopeViewer
(Figure 4). The curators use the php tool and
EpitopeViewer as part of the curation process and to
check for errors.
EpitopeViewer allows the user to visualize, render and
analyze the structure and save structural and contact
views as high-quality pictures for publication (9).
Figur 4 shows an example of how the EpitopeViewer
can be used to analyze speciﬁc inter-molecular contacts.
The residue Arg53 of the antibody light chain (Figure 3)
was curated as part of the paratope; however, it can be
seen that it is located relatively far from the nearest
epitope atom (5.4A ˚ ) (Figure 4A). At the same time,
another light chain residue, Ser30, which was not
curated as part of the paratope, contacts the epitope
residues through van der Waals and 4-A ˚ interactions
(Figure 4B).
Additional detailed information on the 3D structure
is captured in free text form in the ‘Assay Comments’
ﬁeld (bottom of Figure 3). This can, for example,
provide information on antigen and receptor
conformational changes and comparison with other
relevant structures if this information is mentioned in
the paper. Also, the user can get further details on the
PDB website via the PDB ID hyperlink in the ‘Complex
PDB ID’ ﬁeld.
QUERYING IEDB-3D
Since IEDB-3D is fully integrated within IEDB, structural
data, both curated and calculated, and all accompanying
information can be queried using the multiple search
capabilities implemented as part of the IEDB web site
and described in this section.
On the IEDB home page (Figure 1), epitopes can be
searched by epitope sequence, epitope source organism,
source antigen and the immune recognition context,
including the type of response (B-cell, T-cell or MHC-
binding), host organism and MHC allele. If epitopes
curated from 3D structures satisfy the search criteria,
they will be retrieved together with all other epitopes
curated in IEDB.
Using the keyword search option on the IEDB
hom page (the box is located in the right top corner of
the page, Figure 1, red arrow), data are retrieved by
keywords, PDB ID or SwissProt/GenBank ID; the
keyword search runs throughout all ﬁelds in the
database. In addition, the user can explicitly qualify
what identiﬁers to search for when using the option
‘Search by Identiﬁer’ from the ‘Search’ dropdown menu
on the home page (Figure 1, yellow box). This type of
search can be done, using IEDB internal identiﬁers,
PDB ID, PubMed ID and CHEBI ID.
The ‘Search’ dropdown menu on the home page
allows advanced search of any speciﬁed ﬁeld in the
database, including the ﬁelds related to 3D structure.
For example, on the ‘B Cell Search’ webpage, the
search ﬁelds related to 3D structure are made visible by
clicking the ‘+’ sign next to ‘3D Structure of Complex’
within the ‘B Cell Assay’ subsection. Figure 5A shows
how to search on the ‘B Cell Search’ page for the
structures of antigens in complex with antibodies
obtained via in vivo administration/immunization with
Toxoplasma gondii and containing tryptophan (W) in the
paratope (residues in the antibody interacting with the
antigen). The result of this query is a single epitope that
was curated from the structure with the PDB ID 1YNT
(Figure 3).
Alternatively, epitopes for which 3D structural
information is available can also be searched for by
specifying a particular type of assay. For example,
the epitope shown in Figure 3 can be found by
specifying the assay type ‘X-ray crystallography’ using
the ‘Assay Finder’ on the ‘B Cell Search’ form.
Additionally, the resolution for the 3D structure can be
speciﬁed.
In addition to the keyword, simple and advanced
searches, epitopes curated from 3D structures can be
accessed via the ‘Browse by 3D Structure’ page provided
in the ‘Browse’ dropdown menu on the IEDB home page
(Figure 1, red box). By expanding the ‘B Cell’, ‘T Cell’ and
‘MHC Binding’ trees the epitopes can be browsed by the
organism that is the source of the antibody, T cell, and
MHC molecule, respectively. This page also provides an
up to date overview on the number of distinct epitope
structures curated in IEDB-3D.
When clicking on an epitope ID (Figure 5C), all assays
in which that epitope is characterized are returned.
Nucleic AcidsResearch, 2011,Vol. 39, Database issue D1167For example, the query shown in Figure 5A returns one
epitope (Figure 5B and C), for which two B-cell response
assays were curated (Figure 5D), one of which describes
the 3D structure (Figure 3) and another, the
immunological assay (not shown).
The query results obtained using either simple or
advanced search options can be exported as a Microsoft
Excel formatted ﬁle and downloaded in either full
(all ﬁelds are present except pairwise contacts) or
compact form (Figure 5C and D).
DATA ACCESS
The entire database, together with structural data both
curated and calculated (including pairwise contacts), can
be downloaded in XML and MySQL formats.
Figure 4. Visualization of 3D structures and contacts. EpitopeViewer screen-shots for the curated (A) and calculated (B) data for the epitope shown
in Figure 3. Epitope residues are in blue. (A) The residue Arg53 of the antibody light chain, which was curated as part of the paratope, is shown in
an all-atom presentation and colored in yellow; the red line shows the distance between this residue and the nearest epitope atom. Another light
chain residue Ser30, which was not curated as part of the paratope, is shown in magenta. This residue is highlighted in yellow in (B) and its
calculated contacts with the epitope are shown as broken lines (cyan, van der Waals interactions; white, 4A ˚ interactions). (C) The fragment of the
XML ﬁle providing calculated contacts between the antibody and antigen [PDB: 1YNT].
D1168 Nucleic AcidsResearch, 2011,Vol. 39, Database issueFigure 5. Example of the IEDB-3D query. (A) The advanced B-cell search page showing the query for 3D structures of antigens in complex with
antibodies obtained via in vivo administration/immunization with Toxoplasma gondii and containing tryptophan (W) in the paratope calculated as the
antibody residues interacting with the antigen at <4A ˚ atomic distance. The result of clicking on the button ‘Search’ (red box) is shown in B.
(B) The result of the search shown in A. The result of clicking on the number of epitopes (red box) is shown in C. (C) The list of epitopes as the
result of the search shown in A. The result of clicking on the epitope ID (red box) is shown in (D). (D) The list of assays for the epitope found using
the query shown in A. The button ‘View 3D Structure’ (red arrow) launches the EpitopeViewer for curated data (Figure 4A). The result of clicking
on the assay ID (red box) is shown in Figure 3.
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